Moolec Science SA (MLEC)
NASDAQ: MLEC · Real-Time Price · USD
0.850
-0.005 (-0.58%)
Nov 21, 2024, 12:54 PM EST - Market open

Moolec Science Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '24 Jun '24 Jun '23 Jun '22 Jun '21 Dec '20
Revenue
5.635.630.91---
Revenue Growth (YoY)
521.53%521.53%----
Cost of Revenue
5.155.151.05---
Gross Profit
0.470.47-0.14---
Selling, General & Admin
7.767.765.062.631.80.42
Research & Development
1.771.771.350.991.20.54
Other Operating Expenses
-0.02-0.020.10.040.190.01
Operating Expenses
9.529.5249.223.653.190.96
Operating Income
-9.04-9.04-49.36-3.65-3.19-0.96
Interest Expense
-1.17-1.17-0.16-0--
Interest & Investment Income
1.391.390.69---
Earnings From Equity Investments
-----0.78-
Currency Exchange Gain (Loss)
-3.42-3.42-1.39-0.01--
Other Non Operating Income (Expenses)
3.353.350.71-0.86--
EBT Excluding Unusual Items
-8.89-8.89-49.5-4.53-3.97-0.96
Merger & Restructuring Charges
---3.54---
Gain (Loss) on Sale of Investments
0.530.531.01---
Pretax Income
-8.36-8.36-52.02-4.53-3.97-0.96
Income Tax Expense
-1.05-1.05-0.23---
Net Income
-7.31-7.31-51.79-4.53-3.97-0.96
Net Income to Common
-7.31-7.31-51.79-4.53-3.97-0.96
Shares Outstanding (Basic)
383834313029
Shares Outstanding (Diluted)
383834313029
Shares Change (YoY)
9.88%9.88%11.18%2.51%3.77%-
EPS (Basic)
-0.19-0.19-1.50-0.15-0.13-0.03
EPS (Diluted)
-0.19-0.19-1.50-0.15-0.13-0.03
Free Cash Flow
-9.49-9.49-7.53-1.891.96-7.8
Free Cash Flow Per Share
-0.25-0.25-0.22-0.060.06-0.27
Gross Margin
8.40%8.40%-15.83%---
Operating Margin
-160.76%-160.76%-5453.72%---
Profit Margin
-129.99%-129.99%-5722.22%---
Free Cash Flow Margin
-168.65%-168.65%-831.58%---
EBITDA
-8.16-8.16-49.24-3.65--
EBITDA Margin
-145.00%-145.00%----
D&A For EBITDA
0.890.890.120--
EBIT
-9.04-9.04-49.36-3.65-3.19-0.96
EBIT Margin
-160.76%-160.76%----
Source: S&P Capital IQ. Standard template. Financial Sources.